Related Experiment Videos
[Complicated Horton's syndrome: therapeutic modalities]
Christian Agard1, Jacques-Henri Barrier
1Service de médecine interne B, Hôpital Hôtel-Dieu, CHU de Nantes. christian.agard @chu-nantes.fr
Presse Medicale (Paris, France : 1983)
|March 18, 2004
Summary
Managing complicated Horton's syndrome requires careful consideration of therapeutic challenges. This includes addressing ocular and large vein involvement, corticosteroid resistance or dependence, and minimizing long-term corticosteroid morbidity with alternative treatments.
Area of Science:
- Rheumatology
- Ophthalmology
- Vascular Medicine
Context:
- Horton's syndrome presents complex cases including ocular and large vein involvement.
- Corticosteroid resistance and dependence pose significant therapeutic challenges.
- Prolonged corticosteroid therapy is associated with high morbidity rates.
Purpose:
- To outline therapeutic strategies for complicated forms of Horton's syndrome.
- To discuss management principles for ocular and large vein involvement.
- To explore alternative treatments for corticosteroid-dependent cases and mitigate therapy-related complications.
Summary:
- Complicated Horton's syndrome necessitates aggressive initial treatment (1mg/kg/d prednisone) for ocular and large vein involvement.
- Heparin followed by antiplatelet agents are proposed for vascular complications, though evidence is limited.
- Alternative immunosuppressants (azathioprine, methotrexate, dapsone, hydroxychloroquine) and bisphosphonates for osteoporosis are crucial for managing corticosteroid-dependent or long-term therapy.
Impact:
- Provides a framework for managing challenging Horton's syndrome presentations.
- Highlights the need for evidence-based guidelines for anticoagulation and immunosuppressive therapies.
- Emphasizes proactive management of corticosteroid-induced side effects like osteoporosis.